ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,247.79
-0.41%
Dow Jones
39,112.16
-0.76%
Gold vs US Dollar
2,320.18
-0.02%
Brent Oil
84.305
0.14%
Bitcoin
61,992.68
0.31%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Petros Pharmaceuticals Inc (PTPI)

  7. Petros Pharmaceuticals Inc (PTPI) News

Petros Pharmaceuticals (PTPI)

Petros Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PTPI
DateTimeSourceHeadlineSymbolCompany
31/05/202422:07Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:PTPIPetros Pharmaceuticals Inc
21/05/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PTPIPetros Pharmaceuticals Inc
14/05/202412:00GlobeNewswire Inc.Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros PharmaceuticalsNASDAQ:PTPIPetros Pharmaceuticals Inc
12/01/202421:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
29/12/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
28/12/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
26/12/202322:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTPIPetros Pharmaceuticals Inc
26/12/202322:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTPIPetros Pharmaceuticals Inc
26/12/202322:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTPIPetros Pharmaceuticals Inc
30/11/202321:07Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:PTPIPetros Pharmaceuticals Inc
30/11/202321:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PTPIPetros Pharmaceuticals Inc
15/11/202322:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PTPIPetros Pharmaceuticals Inc
15/11/202322:00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:PTPIPetros Pharmaceuticals Inc
02/10/202313:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
19/09/202321:36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PTPIPetros Pharmaceuticals Inc
19/09/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PTPIPetros Pharmaceuticals Inc
15/09/202322:16Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:PTPIPetros Pharmaceuticals Inc
15/09/202321:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
25/08/202322:08Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PTPIPetros Pharmaceuticals Inc
15/08/202322:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
15/08/202322:01Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PTPIPetros Pharmaceuticals Inc
14/08/202322:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PTPIPetros Pharmaceuticals Inc
11/08/202321:31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PTPIPetros Pharmaceuticals Inc
21/07/202321:30Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PTPIPetros Pharmaceuticals Inc
13/07/202321:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
28/04/202323:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTPIPetros Pharmaceuticals Inc
28/04/202323:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTPIPetros Pharmaceuticals Inc
12/04/202323:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTPIPetros Pharmaceuticals Inc
12/04/202323:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTPIPetros Pharmaceuticals Inc
12/04/202323:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTPIPetros Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PTPI

Your Recent History

LSE
SHEL
Shell
LSE
KOS
Kosmos Energy
LSE
ULT
Ultrasis
LSE
GMET
Golden Metal Resources
LSE
BARC
Barclays
LSE
LLOY
Lloyds Banking
LSE
GDR
Genedrive
LSE
PANR
Pantheon Resources
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved